X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SUVEN LIFE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SUVEN LIFE DR. DATSONS LABS/
SUVEN LIFE
 
P/E (TTM) x -10.9 17.2 - View Chart
P/BV x 0.2 3.6 4.6% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 DR. DATSONS LABS   SUVEN LIFE
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SUVEN LIFE
Mar-18
DR. DATSONS LABS/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs126251 50.1%   
Low Rs31155 19.9%   
Sales per share (Unadj.) Rs133.049.1 270.7%  
Earnings per share (Unadj.) Rs0.29.7 1.6%  
Cash flow per share (Unadj.) Rs6.611.4 58.0%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs128.860.3 213.6%  
Shares outstanding (eoy) m31.66127.28 24.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.1 14.2%   
Avg P/E ratio x516.120.9 2,471.9%  
P/CF ratio (eoy) x11.817.8 66.5%  
Price / Book Value ratio x0.63.4 18.1%  
Dividend payout %015.4 0.0%   
Avg Mkt Cap Rs m2,47725,825 9.6%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m56613 9.1%   
Avg. sales/employee Rs ThNM5,832.6-  
Avg. wages/employee Rs ThNM571.5-  
Avg. net profit/employee Rs ThNM1,153.8-  
INCOME DATA
Net Sales Rs m4,2116,253 67.3%  
Other income Rs m79233 33.8%   
Total revenues Rs m4,2896,485 66.1%   
Gross profit Rs m5691,982 28.7%  
Depreciation Rs m204213 95.9%   
Interest Rs m43046 929.2%   
Profit before tax Rs m131,955 0.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6718 0.8%   
Profit after tax Rs m51,237 0.4%  
Gross profit margin %13.531.7 42.6%  
Effective tax rate %48.036.7 130.7%   
Net profit margin %0.119.8 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,8525,622 121.9%   
Current liabilities Rs m6,7111,168 574.7%   
Net working cap to sales %3.371.2 4.7%  
Current ratio x1.04.8 21.2%  
Inventory Days Days16181 197.5%  
Debtors Days Days31836 886.5%  
Net fixed assets Rs m3,6733,325 110.5%   
Share capital Rs m317127 248.7%   
"Free" reserves Rs m3,7617,547 49.8%   
Net worth Rs m4,0787,674 53.1%   
Long term debt Rs m1,67114 12,020.1%   
Total assets Rs m12,6339,135 138.3%  
Interest coverage x1.043.2 2.4%   
Debt to equity ratio x0.40 22,622.6%  
Sales to assets ratio x0.30.7 48.7%   
Return on assets %3.414.0 24.5%  
Return on equity %0.116.1 0.7%  
Return on capital %7.726.0 29.5%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9645,066 19.0%   
Fx outflow Rs m6072,001 30.3%   
Net fx Rs m3573,065 11.6%   
CASH FLOW
From Operations Rs m1,345699 192.3%  
From Investments Rs m-2,256-6 36,977.0%  
From Financial Activity Rs m-1,200-577 207.9%  
Net Cashflow Rs m-2,111116 -1,814.9%  

Share Holding

Indian Promoters % 4.5 63.4 7.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 1.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 36.5 257.8%  
Shareholders   20,807 37,287 55.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ORCHID PHARMA LTD  CIPLA  ABBOTT INDIA  UNICHEM LAB  WYETH LTD  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty Crosses 11,500-Mark; L&T Surges 4% on Buyback News(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.2% while the Hang Seng is up 0.7%.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

SUVEN LIFE Announces Quarterly Results (4QFY18); Net Profit Up 56.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SUVEN LIFE has posted a net profit of Rs 625 m (up 56.0% YoY). Sales on the other hand came in at Rs 2 bn (up 18.6% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS